{"id":"W2066711959","doi":"10.1016/j.rmed.2015.02.005","title":"A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with chronic obstructive pulmonary disease","year":2015,"lang":"en","type":"article","venue":"Respiratory Medicine","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Crossover study; Agonist; Double blind; Anesthesia; Pharmacology; Internal medicine; Placebo; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00245103,0.002557639,0.005173645,0.0006561014,0.0006583331,0.001278917,0.001239515,0.002971599,0.005983268],"category_scores_gemma":[0.003139239,0.001191799,0.002017905,0.0005477173,0.002310875,0.001561445,0.0005678989,0.003028885,0.001420604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006689908,"about_ca_system_score_gemma":0.00143335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005123214,"about_ca_topic_score_gemma":0.0007845829,"domain_scores_codex":[0.9986517,0.0006669704,0.0001090257,0.0002869113,0.00009580848,0.00018961],"domain_scores_gemma":[0.9973282,0.0008075826,0.0005431272,0.0002961129,0.0002055903,0.0008194355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9847831,0.008001603,0.0001693623,0.0002184753,0.0001889928,0.00001707042,0.00003307562,0.0001014186,0.003272526,0.0000305231,0.0001466665,0.003037128],"study_design_scores_gemma":[0.9317952,0.067128,0.0004575519,0.000007934138,0.00008054676,0.00001085036,0.000007118635,0.0001183789,0.0002297579,0.00003589937,0.0001199978,0.000008705149],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895125,0.001490396,0.0008938169,0.0004211054,0.0007947578,0.005185161,0.0007176184,0.0001357428,0.0008488502],"genre_scores_gemma":[0.9754508,0.001409429,0.00325437,0.001165394,0.001076685,0.01303445,0.001088186,0.00004993568,0.003470788],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005983268,"threshold_uncertainty_score":0.02001601,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1251470086507686,"score_gpt":0.345273865195002,"score_spread":0.2201268565442333,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}